Big E on Substack

Idaho Health Board Ends State-Funded COVID Vaccine — Now It’s Time for Others to Follow Suit. By Niklas Kleinworth (11/14/24)

idahofreedom.org/idaho-…

~Niklas Kleinworth, Idaho Freedom foundation (IFF)
The Southwest District Board of Health recently became the first in the nation to stop providing government-subsidized COVID-19 vaccinations. This move recognizes the extent of public distrust of the vaccine and saves hundreds of thousands in taxpayer funds as a bonus. Now, it is time for Idaho’s remaining health districts — and others across the nation — to consider following suit.
Idahoans’ mounting distrust of the vaccine — backed by new evidence of its effects and negative personal experiences — warrant the board’s skepticism and ultimate withdrawal from the program.

Niklas Kleinworth’s article about the Southwest District Health’s (SWDH) withdrawal of state-funded COVID shots calls for all Idaho Health Districts to stop offering these injections. He briefly explained that the shots have negative efficacy and adverse effects, delved into the low uptake among the public, then focused on fiscal impacts of these shots.

Key Points

Millions of dollars support COVID “vaccination” administration in Idaho’s seven public health districts.
Central District Health (CDH) — serving Ada, Boise, Elmore, and Valley counties — had nearly $1 million in this funding last fiscal year and just over $500K in funding this year.
SWDH decision to end the COVID vaccination program would save $620,000 this year.
Federal funding enables health districts to offer the COVID shots at cost.
Available support exceeded $1.3 million in federal grant funding and more than six staffers in the prior fiscal year for SWDH alone.
Idahoans submitted hundreds of comments expressing their disapproval of the SWDH COVID vaccination program.
Consumers who see the COVID “vaccine” as safe, effective, and valuable can purchase it like any other medication. But taxpayers shouldn’t be forced to make that purchase by stocking vaccines no one wants, lining the pockets of pharmaceutical companies.

Related Documentation